G. Wagner et al. / Inorganica Chimica Acta 336 (2002) 147ꢁ
/
150
149
17
1
spectrometers, all nuclei except O at room temperature
7
1
5
(150 Hz). N NMR (CDCl ): d 59.2 (5.5 Hz).
3
O
1
7
(
r.t.), whereas O was measured at 50 8C. For assign-
NMR (CDCl ): d 1209 (370 Hz, Vꢁ
/
O), 386 (1870 Hz, 3
0.58, C H O). EIꢁMS: m/z 321
3
1
13
24
O). [a]
D
ment of the H and C signals and conformational
analysis, H,H-COSY with double quantum filter, HET-
COR, HMQC, HMBC, and one dimensional NOE
Vꢀ
/
ꢂ
/
89.78 (cꢃ
/
/
3
6
ꢂ
ꢂ
ꢂ
[M] , 303 [Mꢀ
/
H O] , 291 [MꢀCH O] , 273 (100%)
/
2
2
ꢂ
2 14 24 4
[MꢀH OꢀCH O] . Anal. Calc. for C H NO V: C,
/
/
2
5
1
difference spectra were used. V chemical shifts are
52.34; H, 7.53; N, 4.36. Found: C, 52.51; H, 7.75; N,
4.31%.
given relative to neat OVCl ꢃ0 ppm, with half height
/
3
1
5
17
line widths in parenthesis. N and O NMR spectra
were measured in natural abundance in direct detection
2.2. (1?R,3S)-5-Aza-6?,6?-dimethyl-1-oxo-1-vanada-
2,8,9-trioxabicyclo[3.3.3]undecane-3-spiro-2?-
bicyclo[3.1.1]heptane (3b)
1
7
mode, using 1.5 M solutions of the compound. For
O
NMR spectra, an aquisition time of 0.031 s and a
relaxation delay of 0.002 s was applied. Chemical shifts
1
5
Yield: 750 mg (78%), m.p. 248 8C. IR (cmꢀ1): 955 s
are given relative to H Oꢃ0 ppm. N spectra were
/
2
1
O). H NMR (CDCl ): d 0.94 (s,
recorded after addition of Cr(acac) (0.03 M) as relaxa-
n(Vꢁ
/
O), 630 m n(Vꢀ
/
3
3
tion reagent, using inverse gated decoupling, an acquisi-
tion time of 1 s and a relaxation delay of 3 s. Chemical
shifts are given relative to nitromethane (50% in
3H, 13H or 14H), 1.24 (s, 3H, 13H or 14H), 1.57 (d, 10.5
Hz, 1H, 12H anti to C8), 1.78 (dm, 8.5 Hz, 1H, 10H),
1.89 (m, 1H, 9H), 1.91 (m, 1H, 10H), 1.96 (m, 1H, 7H),
2.04 (m, 1H, 11H), 2.10 (m, 1H, 11H), 2.14 (m, 1H, 12H
syn to C-8), 3.01 (m, 1H, 4H or 6H), 3.05 (m, 1H, 6H or
4H), 3.07 (m, 1H, 4H or 6H), 3.08 (d, 13.5 Hz, 1H, 2H),
3.17 (m, 1H, 6H or 4H), 3.22 (d, 13.2 Hz, 1H, 2H), 4.56
CDCl )ꢃ379.6 ppm. Chemical shifts from the literature
/
3
are converted to this scale.
A suspension of V O (546 mg, 3 mmol) in dry EtOH
2
5
(
filtered. The solid, assumed to be unchanged V O , was
120 ml) was refluxed overnight, cooled to r.t. and
1
3
(m, 4H, 3H and 5H). C NMR (CDCl ): d 23.8 (C13 or
3
2
5
dried and weighted. From this weight, the amount of
OV(OEt)3 in the filtrate was calculated. Typically,
C14), 24.8 (C10), 27.0 (C12), 27.3 (C13 or C14), 33.8
(C11), 38.2 (C8), 40.1 (C9), 54.9 (C7), 55.9 (C4 or C6),
56.8 (C4 or C6), 66.7 (C2), 73.6 (C3 or C5), 74.5 (C3 or
solutions containing approximately
3
mmol of
OV(OEt) were obtained [9]. They were treated with a
5
1
C5), 89.7 (C1). V NMR (CDCl ): d ꢀ
/
400.4 (174 Hz).
ꢂ
3
3
24
D
solution of one equivalent of the corresponding chiral
triethanolamine in 5 ml of EtOH at r.t. for 2 h. Complex
[a]
303 [Mꢀ
CH O] , 261 [Mꢀ
ꢂ
/
8.08 (cꢃ
/
0.25, C H O). EIꢁ
/
MS: m/z 321 [M] ,
ꢂ
3
6
ꢂ
/
H O] , 291 [Mꢀ
/
CH O] , 273 [Mꢀ
/
H Oꢀ
/
2
2
2
ꢂ
ꢂ
ꢂ
3
b precipitates directly from the reaction mixture as a
/
2CH O] , 183 [Mꢀ
/
pinanone] ,
2
2
ꢂ
colourless powder which is filtered off and dried in
vacuo. The complexes 3a and 3c are obtained as
crystalline pale yellow solids upon slow evaporation of
approximately 90% of the solvent, filtration and drying
in vacuo.
153 (100%) [Mꢀ
/
pinanoneꢀ
/
H O] . Anal. Calc. for
2
C H NO V: C, 52.34; H, 7.53; N, 4.36. Found: C,
52.68; H, 7.39; N, 4.50%.
1
4
24
4
2.3. (3S,2?S?,-5?R)-5-Aza-5?-methyl-2?-(1-
methylethyl)-1-oxo-1-vanada-2,8,9-
trioxabicyclo[3.3.3.]undecane-3-spiro-1?-cyclohexane
(3c)
2
1
.1. (3R,6S,8R)-5-Aza-3-methyl-6-(1-methylethenyl)-
-oxo-1-vanada-2,12,13-
3
,8
trioxatricyclo[7.3.3.0] pentadecane (3a)
ꢀ
1
Yield: 770 mg (76%), m.p. 200 8C. IR (cm ): 965 s
ꢀ
1
1
O). H NMR (CDCl ): d 0.76 (m,
Yield: 530 mg (55%), m.p. 214 8C (dec.). IR (cm ):
n(Vꢁ
/
O), 635 m n (Vꢀ
/
3
1
9
(
1
(
65 s n(Vꢁ
s, 3H, 11H), 1.49 (m, 1H, 7H ax.), 1.56 (m, 1H, 8H ax.),
.60 (dm, 10.8 Hz, 1H, 7H eq.), 1.72 (s, 3H, 14H), 1.80
td, 13.2 Hz, 5.7 Hz, 1H, 10H ax.), 1.99 (dm, 10.8 Hz,
/
O), 630 m n(Vꢀ
/
O). H NMR (CDCl ): d 1.39
1H, 9H), 0.79 (d, 6.0 Hz, 3H, 14H or 15H), 0.86 (d, 7.0
Hz, 3H, 12H), 0.88 (d, 6.2Hz, 3H, 14H or 15H), 1.04 (m,
1H, 7H), 1.06 (m, 1H, 11H), 1.46 (dquart., 12.4 Hz, 3.0
Hz, 1H, 8H), 1.55 (dt, 12.9 Hz, 2.7 Hz, 1H, 8H), 1.68 (m,
1H, 9H), 1.71 (m, 1H, 10H), 1.96 (m, 1H, 11H), 1.99 (m,
1H, 13H), 2.92 (d, 14.1 Hz, 1H, 2H), 3.00 (dd, 11.4 Hz,
5.7 Hz, 1H, 4H or 6H), 3.07 (td, 12.3 Hz, 3.6 Hz, 1H, 4H
or 6H), 3.20 (td, 12.1 Hz, 3.2 Hz, 1H, 4H or 6H), 3.26
(m, 1H, 4H or 6H), 3.40 (d, 14.4 Hz, 1H, 2H), 4.49 (br,
1H, 3H§ or 5H§), 4.59 (td, 12.2 Hz, 4.2 Hz, 1H, 3Hƒ or
5Hƒ), 4.60 (br, 1H, 3H§ or 5H§), 4.64 (td, 12.0 Hz,
3
1
1
H, 8H eq.), 2.12 (dm, 13.5 Hz, 1H, 10H eq.), 2.51 (m,
H, 9H eq.), 2.75 (dd, 13.2 Hz, 4.8 Hz, 1H, 6H?), 2.87
(
1
(
td, 12.6 Hz, 5.7 Hz, 1H, 4H), 2.95 (dd, 13.2 Hz, 2.7 Hz,
H, 2H ax.), 3.09 (dd, 12.9 Hz, 3.9 Hz, 1H, 4H?), 3.32
td, 12.6 Hz, 6.6 Hz, 1H, 6H (NOE to 11H)), 4.38 (br,
1
1
1
H, 3H§), 4.57 (br, 1H, 5H§), 4.60 (td, 12.0 Hz, 3.9 Hz,
H, 3Hƒ), 4.74 (td, 12.0 Hz, 4.2 Hz, 1H, 5Hƒ), 4.80 (‘s’,
1
3
H, 13-H trans to CH 14), 4.93 (‘s’, 1H, 13H cis to
1
3.9Hz, 1H, 3Hƒ or 5Hƒ). C NMR (CDCl ): d 18.1
3
3
3
CH 14). C NMR (CDCl ): d 22.6 (C14), 23.3 (C11),
3
(C14 or C15), 21.1 (C8), 22.2 (C14 or C15), 23.6 (C12),
26.6 (C13), 27.8 (C10), 34.3 (C9), 48.5 (C7), 51.9 (C11),
3
2
5
1
5.1 (C10), 25.9 (C8), 38.6 (C9), 39.2 (C7), 50.7 (C6),
3.2 (C4), 62.6 (C2), 74.3 (C3), 75.5 (C5), 89.7 (C1),
56.8 (C4 or C6), 59.3 (C4 or C6), 62.6 (C2), 74.3 (C3 or
51
5
1
11.2 (C13), 145.6 (C12). V NMR (CDCl ): d ꢀ
/
380
C5), 74.9 (C3 or C5), 95.1 (C1). V (CDCl ): d ꢀ392
/
3
3